Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Cash Flow Reinvestment Rate
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow Reinvestment Rate of 2.39x as of September 2025, reinvesting CN¥150.58 Million (capex CN¥150.58 Million ) from operating cash flow of CN¥62.99 Million. Explore Tonghua Dongbao Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Tonghua Dongbao Pharmaceutical Co Ltd across 25 annual periods. Also explore 600867 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tonghua Dongbao Pharmaceutical Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Tonghua Dongbao Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600867 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.64x | CN¥1.82 Billion | CN¥689.23 Million | CN¥517.69 Million | ▲ +91.0% |
| 2024 | 1.38x | CN¥635.44 Million | CN¥459.74 Million | CN¥568.73 Million | ▲ +63.3% |
| 2023 | 0.85x | CN¥729.22 Million | CN¥861.52 Million | CN¥348.13 Million | ▼ -44.2% |
| 2022 | 1.52x | CN¥1.31 Billion | CN¥863.09 Million | CN¥491.63 Million | ▲ +50.2% |
| 2021 | 1.01x | CN¥1.15 Billion | CN¥1.13 Billion | CN¥600.75 Million | ▲ +91.2% |
| 2020 | 0.53x | CN¥629.59 Million | CN¥1.19 Billion | CN¥479.59 Million | ▲ +46.2% |
| 2019 | 0.36x | CN¥416.13 Million | CN¥1.15 Billion | CN¥293.13 Million | ▼ -59.6% |
| 2018 | 0.89x | CN¥784.07 Million | CN¥876.94 Million | CN¥773.07 Million | ▲ +255.9% |
| 2017 | 0.25x | CN¥241.50 Million | CN¥961.19 Million | CN¥185.50 Million | ▼ -85.4% |
| 2016 | 1.72x | CN¥1.25 Billion | CN¥725.76 Million | CN¥411.53 Million | ▼ -12.1% |
| 2015 | 1.96x | CN¥576.63 Million | CN¥294.58 Million | CN¥400.09 Million | ▲ +279.9% |
| 2014 | 0.52x | CN¥106.08 Million | CN¥205.89 Million | CN¥106.08 Million | ▼ -40.2% |
| 2013 | 0.86x | CN¥190.36 Million | CN¥221.06 Million | CN¥190.36 Million | ▼ -30.8% |
| 2012 | 1.24x | CN¥241.83 Million | CN¥194.32 Million | CN¥241.83 Million | ▲ +174.7% |
| 2010 | 0.45x | CN¥72.66 Million | CN¥160.40 Million | CN¥72.66 Million | ▼ -4.8% |
| 2009 | 0.48x | CN¥79.07 Million | CN¥166.20 Million | CN¥79.07 Million | ▼ -22.5% |
| 2008 | 0.61x | CN¥56.67 Million | CN¥92.31 Million | CN¥56.67 Million | ▼ -71.3% |
| 2007 | 2.14x | CN¥258.34 Million | CN¥120.94 Million | CN¥258.34 Million | ▲ +17.6% |
| 2006 | 1.82x | CN¥286.90 Million | CN¥158.00 Million | CN¥286.90 Million | ▲ +40.3% |
| 2005 | 1.29x | CN¥119.38 Million | CN¥92.23 Million | CN¥119.38 Million | ▼ -65.3% |
| 2004 | 3.73x | CN¥49.08 Million | CN¥13.17 Million | CN¥49.08 Million | ▲ +193.0% |
| 2003 | 1.27x | CN¥57.90 Million | CN¥45.51 Million | CN¥57.90 Million | ▼ -54.5% |
| 2002 | 2.79x | CN¥89.41 Million | CN¥31.99 Million | CN¥89.41 Million | ▲ +270.9% |
| 2001 | 0.75x | CN¥88.69 Million | CN¥117.73 Million | CN¥88.69 Million | ▼ -58.2% |
| 2000 | 1.80x | CN¥52.46 Million | CN¥29.12 Million | CN¥52.46 Million | — |